Identify possible new venture opportunities and the next steps
Understand what makes a good opportunity for a new venture
Assess and improve new business proposals
Develop a value proposition
Analyse views of stakeholders
Explore and choose the most relevant business model
Articulate the opportunities and challenges of the business proposal
Delegates will have the opportunity to hear from new venture development practitioners and those with corporate and venture capital experience. There will also be ample opportunity for networking with other delegates, the course team and other contributors
PLEASE NOTE: There may be a requirement for delegates to undertake some pre-course work/reading before the course begins.
Who should attend?
- Relevant job titles: Relevant to anyone working in KE
- Relevant sectors/organisations: Higher education and public sector research environment, incubators or accelerators who support new venture creation
- Experience needed: KE field experience and/or a little practical experience in company formation. Delegates might have significant experience in TT/KT or KE, but little practical experience of new venture formation and may be looking to take the first steps in assessing and supporting new venture opportunities.
- Supporting courses: None required
- Other: The course is an ideal primer for New Venture Creation 2 which deals with these issues in greater detail and gives additional insight in how to form a high-growth company with VC finance
Forming new companies can be a key enabler of developing new technologies and priming them for the market place, and a key tool for the knowledge transfer professional. It can facilitate economic benefits including a financial return to inventors and their institutions whilst creating new jobs and services of benefit to the local economy and beyond. New ventures may also enjoy symbiotic relationships with their parent institutions investing in further research and securing rights to develop arising IP. There is an increasing expectation that Universities and research institutes should be skilled at setting up actively managing their relationships with new venture companies and company creation is a key element in the mix of instruments that allow Universities to deliver impact from their funding inputs and research outputs. Supporting new venture creation can be a challenging and immersive experience and this course gives a framework for knowing whether to embrace this exciting challenge.
Stuart Wilkinson is Head of the Knowledge Exchange and Impact Team in the Research Services office of the University of Oxford. Stuart's current role is to support the University's engagement and partnership with external organisations across the institution to maximise the impact of the research, including regional partners including the LEP. Previously Stuart worked as a consultant advising and training governments, companies and research organisations on technology development, intellectual property discovery, commercialisation strategy and business planning. Stuart also worked for Isis Innovation where he was responsible for evaluating, protecting and commercialising intellectual property in materials, engineering, energy and imaging technologies, including developing translational funding applications, business plans and negotiating investment for spin-out businesses. Stuart has a DPhil and MEng in BioMaterials and Materials Science from the University of Oxford.
Dr Rich Ferrie is Director of Technology Transfer at University College Cork, having previously been Director of Operations and Head of UMIP - the technology transfer Division of UMI3 Ltd. He joined UMIP's predecessor company, MIL in 2000 after 11 years in various scientific and commercial roles with the diagnostics business of AstraZeneca culminating with leadership of its Sales and Marketing function internationally. A Biochemistry graduate (Sussex), Rich gained a PhD in Molecular Biology from the University of Reading. After a short period of post-doctoral research with the UK Forensic Science Service, Rich continued his work developing DNA fingerprinting technology for the Cellmark business unit of ICI Diagnostics.